144 related articles for article (PubMed ID: 7738627)
1. Pharmacokinetics of all-trans-retinoic acid administered on an intermittent schedule.
Adamson PC; Bailey J; Pluda J; Poplack DG; Bauza S; Murphy RF; Yarchoan R; Balis FM
J Clin Oncol; 1995 May; 13(5):1238-41. PubMed ID: 7738627
[TBL] [Abstract][Full Text] [Related]
2. Phase I trial and pharmacokinetic study of all-trans-retinoic acid administered on an intermittent schedule in combination with interferon-alpha2a in pediatric patients with refractory cancer.
Adamson PC; Reaman G; Finklestein JZ; Feusner J; Berg SL; Blaney SM; O'Brien M; Murphy RF; Balis FM
J Clin Oncol; 1997 Nov; 15(11):3330-7. PubMed ID: 9363862
[TBL] [Abstract][Full Text] [Related]
3. [Pharmacokinetic studies of all-trans retinoic acid (ATRA) and pilot study of intermittent schedule of ATRA and chemotherapy in childhood acute promyelocytic leukemia. Children's Cancer and Leukemia Study Group].
Hirota T; Fujimoto T; Konno K; Sakakibara Y; Katano N; Tsurusawa M; Takitani K; Miyake M
Rinsho Ketsueki; 1997 Nov; 38(11):1170-6. PubMed ID: 9423333
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of all-trans-retinoic acid in Japanese patients with acute promyelocytic leukemia.
Usuki K; Endo M; Osawa M; Kitazume K; Iki S; Urabe A
Int J Hematol; 1996 Jan; 63(1):19-23. PubMed ID: 8713573
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics of all-trans-retinoic acid: clinical implications in acute promyelocytic leukemia.
Adamson PC
Semin Hematol; 1994 Oct; 31(4 Suppl 5):14-7. PubMed ID: 7831580
[TBL] [Abstract][Full Text] [Related]
6. Phase I/II study of intermittent all-trans-retinoic acid, alone and in combination with interferon alfa-2a, in patients with epidemic Kaposi's sarcoma.
Bailey J; Pluda JM; Foli A; Saville MW; Bauza S; Adamson PC; Murphy RF; Cohen RB; Broder S; Yarchoan R
J Clin Oncol; 1995 Aug; 13(8):1966-74. PubMed ID: 7636537
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics of all-trans retinoic acid in pediatric patients with leukemia.
Takitani K; Tamai H; Morinobu T; Kawamura N; Miyake M; Fujimoto T; Mino M
Jpn J Cancer Res; 1995 Apr; 86(4):400-5. PubMed ID: 7775262
[TBL] [Abstract][Full Text] [Related]
8. Pulsed ATRA as single therapy restores long-term remission in PML-RARalpha-positive acute promyelocytic leukemia patients: real time quantification of minimal residual disease. A pilot study.
Visani G; Buonamici S; Malagola M; Isidori A; Piccaluga PP; Martinelli G; Ottaviani E; Grafone T; Baccarani M; Tura S
Leukemia; 2001 Nov; 15(11):1696-700. PubMed ID: 11681409
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics and metabolism of all-trans- and 13-cis-retinoic acid in pulmonary emphysema patients.
Muindi JR; Roth MD; Wise RA; Connett JE; O'Connor GT; Ramsdell JW; Schluger NW; Romkes M; Branch RA; Sciurba FC;
J Clin Pharmacol; 2008 Jan; 48(1):96-107. PubMed ID: 18094222
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics of intravenously administered liposomal all-trans-retinoic acid (ATRA) and orally administered ATRA in healthy volunteers.
Ozpolat B; Lopez-Berestein G; Adamson P; Fu CJ; Williams AH
J Pharm Pharm Sci; 2003; 6(2):292-301. PubMed ID: 12935441
[TBL] [Abstract][Full Text] [Related]
11. Clinical and pharmacokinetic studies of all-trans-retinoic acid in pediatric patients with cancer.
Adamson PC
Leukemia; 1994; 8 Suppl 3():S22-5. PubMed ID: 7808020
[TBL] [Abstract][Full Text] [Related]
12. Pharmacology of all-trans-retinoic acid in children with acute promyelocytic leukemia.
Lanvers C; Reinhardt D; Dübbers A; Wagner-Bohn A; Creutzig U; Ritter J; Boos J
Med Pediatr Oncol; 2003 May; 40(5):293-301. PubMed ID: 12652617
[TBL] [Abstract][Full Text] [Related]
13. All-trans retinoic acid (ATRA) in patients with chronic myeloid leukemia in the chronic phase.
Russo D; Regazzi M; Sacchi S; Visani G; Lazzarino M; Avvisati G; Pelicci PG; Dastoli G; Grandi C; Iacona I; Candoni A; Grattoni R; Galieni P; Rupoli S; Liberati AM; Maiolo AT
Leukemia; 1998 Apr; 12(4):449-54. PubMed ID: 9557600
[TBL] [Abstract][Full Text] [Related]
14. 4-oxo retinoic acid for refractory acute promyelocytic leukemia in children with all-trans retinoic acid therapy.
Takitani K; Tamai H; Morinobu T; Kawamura N; Miyake M; Fujimoto T; Mino M
J Nutr Sci Vitaminol (Tokyo); 1995 Aug; 41(4):493-8. PubMed ID: 8676222
[TBL] [Abstract][Full Text] [Related]
15. [Pharmacokinetics and efficacy of low-dose all-trans retinoic acid in the treatment of acute promyelocytic leukemia].
Chen G; Shen Z; Zhu AP
Zhonghua Nei Ke Za Zhi; 1997 May; 36(5):295-9. PubMed ID: 10374268
[TBL] [Abstract][Full Text] [Related]
16. Effectiveness and pharmacokinetics of low-dose all-trans retinoic acid (25 mg/m2) in acute promyelocytic leukemia.
Castaigne S; Lefebvre P; Chomienne C; Suc E; Rigal-Huguet F; Gardin C; Delmer A; Archimbaud E; Tilly H; Janvier M
Blood; 1993 Dec; 82(12):3560-3. PubMed ID: 8260694
[TBL] [Abstract][Full Text] [Related]
17. All-trans retinoic acid pharmacokinetics and bioavailability in acute promyelocytic leukemia: intracellular concentrations and biologic response relationship.
Agadir A; Cornic M; Lefebvre P; Gourmel B; Jérôme M; Degos L; Fenaux P; Chomienne C
J Clin Oncol; 1995 Oct; 13(10):2517-23. PubMed ID: 7595702
[TBL] [Abstract][Full Text] [Related]
18. Clinical and pharmacokinetic studies of all-trans-retinoic acid in pediatric patients with cancer.
Adamson PC
Leukemia; 1994 Nov; 8(11):1813-6. PubMed ID: 7967727
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics and efficacy of low-dose all-trans retinoic acid in the treatment of acute promyelocytic leukemia.
Chen GQ; Shen ZX; Wu F; Han JY; Miao JM; Zhong HJ; Li XS; Zhao JQ; Zhu J; Fang ZW; Chen SJ; Chen Z; Wang ZY
Leukemia; 1996 May; 10(5):825-8. PubMed ID: 8656678
[TBL] [Abstract][Full Text] [Related]
20. Alterations in tretinoin pharmacokinetics following administration of liposomal all-trans retinoic acid.
Estey E; Thall PF; Mehta K; Rosenblum M; Brewer T; Simmons V; Cabanillas F; Kurzrock R; Lopez-Berestein G
Blood; 1996 May; 87(9):3650-4. PubMed ID: 8611689
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
